Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
link
photo
Tags
achromatopsia
beta-thalassemia
bill cassidy
bluebird bio
boston blog main
boston top stories
clinical trials
deals
dna
fda
gene therapy
harvard pilgrim health care
hemophilia
johnson & johnson
life sciences
luxturna
mark warner
mathai mammen
medicaid
meiragtx
national blog main
national top stories
new york
new york blog main
new york top stories
novartis
patient affordability value and efficiency act
spark therapeutics
spinal muscular atrophy
university of pennsylvania
value based agreements
x-linked retinitis pigmentosa
zolgensma
What
come
2
×
therapy
2
×
age
autism
behavioral
bigger
biggest
day
deal
emerging
form
gave
gene
groundbreaking
j
johnson
medicine's
meiragtx
morning
mysteries
new
ozy
past
perplexing
primarily
probiotic
research
signal
signals
study
suggests
today
treated
treatment
years
Language
Current search:
therapy
×
come
×
@xconomy.com
5 years ago
With $100M MeiraGTx Deal, J&J Signals Bigger Move Into Gene Therapy
@WIRED
8 years ago
Today autism is treated primarily through behavioral therapy. But a new study suggests that treatment may one day come in the form of a probiotic. (via OZY)
